Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Sapio Sciences, the science-aware ™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

According to Research by SNS Insider, The Computational Biology Market Growth is Fueled by Advancements in biotechnology and the rising adoption of personalized medicine.Pune, March 18, 2025 (GLOBE ...